Clinical Trial Update: Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease [Phase 3]

View source ↗

Summary

Phase 3 trial exploring hypnosis as a non-pharmacologic approach to manage pain and symptoms in sickle cell disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Management
• Sickle Cell Disease

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Sickle Cell Disease, Pain Management | Phase 3 | Status: COMPLETED